Skip to main content

Main menu

  • Home
  • Content
    • Current issue
    • Past issues
    • Early releases
    • Collections
    • Sections
    • Blog
    • Infographics & illustrations
    • Podcasts
    • COVID-19 articles
    • Obituary notices
  • Authors & Reviewers
    • Overview for authors
    • Submission guidelines
    • Submit a manuscript
    • Forms
    • Editorial process
    • Editorial policies
    • Peer review process
    • Publication fees
    • Reprint requests
    • Open access
    • Patient engagement
  • Physicians & Subscribers
    • Benefits for Canadian physicians
    • CPD Credits for CMA Members
    • Subscribe to CMAJ Print
    • Subscription prices
    • Obituary notices
  • Alerts
    • Email alerts
    • RSS
  • JAMC
    • À propos
    • Numéro en cours
    • Archives
    • Sections
    • Abonnement
    • Alertes
    • Trousse média 2023
    • Avis de décès
  • CMAJ JOURNALS
    • CMAJ Open
    • CJS
    • JAMC
    • JPN

User menu

Search

  • Advanced search
CMAJ
  • CMAJ JOURNALS
    • CMAJ Open
    • CJS
    • JAMC
    • JPN
CMAJ

Advanced Search

  • Home
  • Content
    • Current issue
    • Past issues
    • Early releases
    • Collections
    • Sections
    • Blog
    • Infographics & illustrations
    • Podcasts
    • COVID-19 articles
    • Obituary notices
  • Authors & Reviewers
    • Overview for authors
    • Submission guidelines
    • Submit a manuscript
    • Forms
    • Editorial process
    • Editorial policies
    • Peer review process
    • Publication fees
    • Reprint requests
    • Open access
    • Patient engagement
  • Physicians & Subscribers
    • Benefits for Canadian physicians
    • CPD Credits for CMA Members
    • Subscribe to CMAJ Print
    • Subscription prices
    • Obituary notices
  • Alerts
    • Email alerts
    • RSS
  • JAMC
    • À propos
    • Numéro en cours
    • Archives
    • Sections
    • Abonnement
    • Alertes
    • Trousse média 2023
    • Avis de décès
  • Visit CMAJ on Facebook
  • Follow CMAJ on Twitter
  • Follow CMAJ on Pinterest
  • Follow CMAJ on Youtube
  • Follow CMAJ on Instagram
Commentary

International legal barriers to Canada’s marijuana plans

Steven J. Hoffman and Roojin Habibi
CMAJ July 12, 2016 188 (10) E215-E216; DOI: https://doi.org/10.1503/cmaj.160369
Steven J. Hoffman
Global Strategy Lab (Hoffman, Habibi), Centre for Health Law, Policy and Ethics, Faculty of Law, University of Ottawa, Ottawa, Ont.; Department of Global Health and Population (Hoffman), Harvard T.H. Chan School of Public Health, Harvard University, Boston, Mass.; McMaster Health Forum (Hoffman), Department of Clinical Epidemiology and Biostatistics, McMaster University, Hamilton, Ont.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: steven.hoffman@uottawa.ca
Roojin Habibi
Global Strategy Lab (Hoffman, Habibi), Centre for Health Law, Policy and Ethics, Faculty of Law, University of Ottawa, Ottawa, Ont.; Department of Global Health and Population (Hoffman), Harvard T.H. Chan School of Public Health, Harvard University, Boston, Mass.; McMaster Health Forum (Hoffman), Department of Clinical Epidemiology and Biostatistics, McMaster University, Hamilton, Ont.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Tables
  • Related Content
  • Responses
  • Metrics
  • PDF
Loading
Submit a Response to This Article
Compose Response

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
References
Author Information
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'. Minimum 7 characters.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'. Minimum 12 characters.
Your organization, institution's or residential address.
Statement of Competing Interests

Vertical Tabs

Jump to comment:

  • Cannabis Legalization in Canada and the International Conventions: Need for Resolve and Leadership
    Benedikt Fischer
    Posted on: 01 June 2016
  • An important discussion at a key moment, but Hoffman and Habibi's article is inaccurate
    Damon Barrett
    Posted on: 25 May 2016
  • Posted on: (1 June 2016)
    Page navigation anchor for Cannabis Legalization in Canada and the International Conventions: Need for Resolve and Leadership
    Cannabis Legalization in Canada and the International Conventions: Need for Resolve and Leadership
    • Benedikt Fischer, Senior Scientist & Professor
    • Other Contributors:

    Hoffman & Habibi [1] correctly observe that the current plan to formally - i.e., on a de jure basis - legalize recreational cannabis use and supply in Canada would violate international drug control treaties (especially the 1961 'Single Convention'). While there have been extensive - and creative - interpretive efforts over decades on whether various cannabis law reform models indeed do violate the international conv...

    Show More

    Hoffman & Habibi [1] correctly observe that the current plan to formally - i.e., on a de jure basis - legalize recreational cannabis use and supply in Canada would violate international drug control treaties (especially the 1961 'Single Convention'). While there have been extensive - and creative - interpretive efforts over decades on whether various cannabis law reform models indeed do violate the international conventions, there can be no doubt that a national legalization scheme as proposed in Canada surely violates the object and spirit of these conventions [2,3]. After all,the international drug conventions centrally enshrine the fundamental principles of prohibition for scheduled illicit drugs (including but not limited to cannabis), consequentially requiring its operationalization by criminal repression of use and supply by its signatories based on the premise that these drugs are disproportionately harmful and need to be purged. A legalization policy, for public health or other reasons, fundamentally disagrees and facilitates the opposite approach as state-based policy. Thus Hoffman & Habibi correctly conclude that such a rejection of international treaties requires appropriate remedy especially from a signatory country which prides itself as a democracy that fundamentally respects and promotes the rule of law.

    However, we do not fully agree with the possible paths for remedy proposed. While Canada may indeed just leave the conventions, it may also denounce and re-accede to them with a reservation that will legally protect its planned legalization policy [4,5]. Reservations to international conventions are a possible - and increasingly common - tool. More than 30 countries have established reservations to the drug control treaties at time of accession, and Bolivia has established precedence for the 'denounce and re-accede' option (which did not meet substantial resistance from other signatories). While the 'denounce and re-accede with reservation' option would likely be the more pragmatic and diplomatically palatable solution for the specific Canadian situation, there may be good strategic reasons for either approach. The international drug control treaties, and the spirit and consequential forces of prohibition they represent and impose on their signatories, are an anachronistic 'yoke' of international law constituting a principal and powerful barrier to modern drug control policies guided by public health [6,7]. This yoke effect extends far beyond cannabis (e.g., to other substances like opioids or stimulants) but also to many other countries - many in the Americas - where impetus or concrete initiatives for drug policy reform is building but which may be too small or insufficiently astute to actively challenge the dictates of the international conventions [8].

    Considering this, we urge Canada not to seek creative circumventions of its currently defined commitments under the conventions. Rather, it should not only demonstrate straight resolve by taking appropriate steps to proactively remedy impending conflict with the international conventions in support of its domestic legalization policy plans, yet also to provide international leadership toward aiding similar public health-oriented drug policy reform endeavours for the benefit of other countries where these are considered. This way, Canada would provide an incremental yet important contribution in moving the global community towards - urgently needed - altogether new international drug control conventions based centrally on public health principles as their essential core in material and spirit.

    Benedikt Fischer, PhD; Institute for Mental Health Research Policy, Centre for Addiction & Mental Health (CAMH) and University of Toronto, Toronto, Canada

    Robin Room, PhD; Centre for Alcohol Policy Research, Turning Point and La Trobe University, Melbourne, Australia

    References

    1. Hoffman SJ, Habibi R. International legal barriers to Canada's marijuana plans. CMAJ 2016; May 16.

    2. Bewley-Taylor DR. Challenging the UN drug control conventions: Problems and possibilities. International Journal of Drug Policy 2003;14(2):171-9.

    3. Bewley-Taylor D, Jelsma M. The UN drug control conventions: The limits of latitude. Amsterdam, The Netherlands: United Nations Drug Control Transnational Institute; 2012. Report No. 18: Legislative Reform of Drug Policies.

    4. Room R, Fischer B, Hall W, Lenton S, Reuter P. Cannabis policy: Moving beyond stalemate. New York, NY: Oxford University Press; 2010.

    5. Room R. Reform by subtraction: The path of denunciation of international drug treaties and reaccession with reservations. Int J Drug Policy 2012; Sep;23(5):401-6.

    6. Room R, Reuter P. How well do international drug conventions protect public health? Lancet 2012;379(9810):84.

    7. Wood E, Werb D, Marshall BD, Montaner JS, Kerr T. The war on drugs: A devastating public-policy disaster. Lancet 2009; Mar 21;373(9668):989-90.

    8. Youngers CA. The drug policy reform agenda in the americas (version 2). Briefing Paper. London, United Kingdom: International Drug Policy Consortium (IDPC); 2013.

    Conflict of Interest:

    None declared

    Show Less
    Competing Interests: None declared.
  • Posted on: (25 May 2016)
    Page navigation anchor for An important discussion at a key moment, but Hoffman and Habibi's article is inaccurate
    An important discussion at a key moment, but Hoffman and Habibi's article is inaccurate
    • Damon Barrett
    • Other Contributors:

    Hoffman and Habibi's article is correct in that to legally regulate cannabis falls outside of the international drug control conventions. They are correct, also, in that these treaties are outdated. It is an important discussion at a key moment. However, the article contains some inaccuracies that require correction.

    The authors assert that depenalisation and decriminalisation violate the drug control treaties. T...

    Show More

    Hoffman and Habibi's article is correct in that to legally regulate cannabis falls outside of the international drug control conventions. They are correct, also, in that these treaties are outdated. It is an important discussion at a key moment. However, the article contains some inaccuracies that require correction.

    The authors assert that depenalisation and decriminalisation violate the drug control treaties. This is incorrect. States granted themselves leeway in the drafting of the treaties to ensure that penal policy remained a domestic concern, and built alternatives to conviction or punishment explicitly into the treaties. The obligation to criminalise possession for personal use, referred to by the authors, is caveated with regard to constitutional limitations. It requires no constitutional amendment to avail of, however, and is further broadened by the additional caveat that states need not criminalise if to do so would be contrary to the basic principles of their legal systems. Here, we might consider such considerations as arbitrariness, fairness and others.

    The authors appear to have misunderstood the extent of what is possible with the constitutional caveat. While it appears numerous times it relates only to penal provisions, as is clear form the treaties, their official commentaries, and, indeed, the travaux preparatoires. It does not refer to the legal regulation of the market. Bolivia, for its part, was not 'leveraging' an 'exception' with its constitutional amendment regarding the coca leaf (nor is this an analogous situation with cannabis in Canada). It sought to amend the status of coca under the treaty first, and when this failed it denounced and re-acceded with a reservation.

    The authors' apparent error in this regard speaks to the second possible option they set out - for Canada to amend its constitution to side step an international obligation. Given the authors' concern with the international rule of law, and their citation of the Vienna Convention on the Law of Treaties, this is an unusual suggestion (its acknowledged unlikelihood of success notwithstanding). States cannot invoke national law to justify non-compliance with international norms. The authors appear to believe that this is allowed for within the drug treaties, but it is not.

    The authors also suggest that a reservation on cannabis would be a possible route to take, but they do not acknowledge the legal challenges this raises. As a post-ratification reservation it is already more difficult to see through than a standard reservation. But it is also by no means certain that this would not also run contrary to the 'object and purpose' of the treaty, which concerned the authors with regard, incorrectly, to depenalisation and decriminalisation. Moreover, the authors mention other areas of international law, so let us imagine gradually removing certain arms from the relatively new Arms Trade Treaty by post-ratification reservations.

    Finally, the authors set out only three possible options. One of them, as we note above, is contrary to international law. Another, as we note above, is problematic. There are other possible routes that engage in a more nuanced way with the legal and political dilemmas at play, all with their positives and negatives. This includes a recognition of Canada's non -compliance with this component of the regime, while seeking multilateral solutions moving forward. There is no reason that this need be 'avoided at all costs' when the costs of cannabis prohibition have been so high, and when the political costs of full denunciation have not yet been calculated. The authors' conclusion is too simplistic, even if their recognition of the inability of Canada to end the prohibition of cannabis without international legal problems is correct.

    From its statements at the UN General Assembly Special Session on the World Drug Problem in April, it is clear that the government recognises these legal issues already, and is moving carefully forward, mindful of the complexities.

    Damon Barrett, Co-director, International Centre on Human Rights and Drug Policy; Visiting Fellow, Human Rights Centre, University of Essex; PhD candidate, University of Stockholm.

    Dr. Rick Lines, Chair, International Centre on Human Rights and Drug Policy; Visiting Fellow, Human Rights Centre, University of Essex.

    Conflict of Interest:

    None declared

    Show Less
    Competing Interests: None declared.
PreviousNext
Back to top

In this issue

Canadian Medical Association Journal: 188 (10)
CMAJ
Vol. 188, Issue 10
12 Jul 2016
  • Table of Contents
  • Index by author

Article tools

Respond to this article
Print
Download PDF
Article Alerts
To sign up for email alerts or to access your current email alerts, enter your email address below:
Email Article

Thank you for your interest in spreading the word on CMAJ.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
International legal barriers to Canada’s marijuana plans
(Your Name) has sent you a message from CMAJ
(Your Name) thought you would like to see the CMAJ web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
International legal barriers to Canada’s marijuana plans
Steven J. Hoffman, Roojin Habibi
CMAJ Jul 2016, 188 (10) E215-E216; DOI: 10.1503/cmaj.160369

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
‍ Request Permissions
Share
International legal barriers to Canada’s marijuana plans
Steven J. Hoffman, Roojin Habibi
CMAJ Jul 2016, 188 (10) E215-E216; DOI: 10.1503/cmaj.160369
Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like

Jump to section

  • Article
    • Footnotes
    • References
  • Figures & Tables
  • Related Content
  • Responses
  • Metrics
  • PDF

Related Articles

  • PubMed
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • Ensuring timely genetic diagnosis in adults
  • The case for improving the detection and treatment of obstructive sleep apnea following stroke
  • Laser devices for vaginal rejuvenation: effectiveness, regulation and marketing
Show more Commentary

Similar Articles

Collections

  • Topics
    • Canadian government
    • Drug regulation
    • Medicine & the law (including forensic medicine)

 

View Latest Classified Ads

Content

  • Current issue
  • Past issues
  • Collections
  • Sections
  • Blog
  • Podcasts
  • Alerts
  • RSS
  • Early releases

Information for

  • Advertisers
  • Authors
  • Reviewers
  • CMA Members
  • CPD credits
  • Media
  • Reprint requests
  • Subscribers

About

  • General Information
  • Journal staff
  • Editorial Board
  • Advisory Panels
  • Governance Council
  • Journal Oversight
  • Careers
  • Contact
  • Copyright and Permissions
CMAJ Group

Copyright 2023, CMA Impact Inc. or its licensors. All rights reserved. ISSN 1488-2329 (e) 0820-3946 (p)

All editorial matter in CMAJ represents the opinions of the authors and not necessarily those of the Canadian Medical Association or its subsidiaries.

To receive any of these resources in an accessible format, please contact us at CMAJ Group, 500-1410 Blair Towers Place, Ottawa ON, K1J 9B9; p: 1-888-855-2555; e: cmajgroup@cmaj.ca

CMA Civility, Accessibility, Privacy

 

Powered by HighWire